A Guide to Clinical Trial Eligibility in the UK

A trial may look promising on paper yet still not be suitable for you. That is not a judgement on the seriousness of your condition or whether you deserve access to new treatment. It means the study has specific safety and research requirements. This guide to clinical trial eligibility explains how those decisions are made, what information you may need and how to approach the process clearly.

What clinical trial eligibility means

Clinical trials test treatments, procedures, diagnostic methods or ways of managing a condition. Before anyone can take part, the research team checks whether they meet the study’s eligibility criteria. These are the rules used to identify the participants a trial needs.

Eligibility criteria are divided into inclusion criteria and exclusion criteria. Inclusion criteria describe the characteristics a participant must have, such as a particular diagnosis, stage of disease, age range or previous treatment history. Exclusion criteria describe factors that make participation unsuitable, often because of safety concerns or because they could affect the reliability of the results.

A trial can be highly relevant to your diagnosis but still not be the right fit. For example, a study may be recruiting people who have not yet received treatment, while another may be designed only for people whose condition has not responded to standard care. Timing can therefore matter as much as the diagnosis itself.

Why trials have strict entry criteria

Research teams need to protect participants while producing results that can be interpreted properly. If a trial includes people with substantially different health circumstances, it can become difficult to establish whether a treatment caused a benefit or side effect.

Safety is the first consideration. An investigational treatment may have unknown risks, interact with other medicines, or be unsuitable for people with impaired kidney or liver function. Pregnancy, active infection, uncontrolled health conditions and recent surgery may also affect whether participation is appropriate.

The criteria also help answer a focused clinical question. A cancer trial, for instance, may examine one treatment in people with a specific tumour type and genetic marker. A study in migraine may require a minimum number of migraine days each month. These boundaries can feel restrictive, but they are part of ethical, regulated research.

The main factors that affect eligibility

Every protocol is different, but several areas are assessed repeatedly. Understanding them can help you identify which studies are worth discussing with your usual clinician or a trial navigation service.

Diagnosis and disease characteristics

The exact diagnosis matters, including subtype, severity, stage and how it has been confirmed. Some trials require pathology, imaging or genetic test results. Others are restricted to a defined symptom pattern or diagnostic score.

For conditions such as cancer, eligibility may depend on the primary site of the cancer, whether it has spread, biomarker results and whether there are measurable areas of disease on a scan. In other specialties, the relevant details may include disease duration, frequency of flare-ups or functional impact.

Previous and current treatment

Most studies specify which treatments participants may have received. You may need to have tried a standard treatment first, or you may need to have had no previous treatment for the condition. There can be a required gap, known as a washout period, between stopping one medicine and starting a trial treatment.

Do not stop prescribed medication to try to meet trial criteria. A treatment change should only be made with advice from the clinician responsible for your care. It may be unsafe, and it does not guarantee that you will become eligible.

General health and medical history

Researchers will ask about medical conditions beyond the illness being studied. Heart disease, respiratory illness, diabetes, seizures, autoimmune conditions and past cancer may be relevant, depending on the trial. They will also review allergies, operations and previous adverse reactions to medicines.

This does not mean that having another condition automatically excludes you. Often, the question is whether it is stable and whether it could increase the risks of the investigational treatment or complicate monitoring.

Medicines, tests and practical requirements

A complete medication list is essential. Include prescriptions, over-the-counter medicines, supplements, herbal products and occasional treatments. Some medicines interact with trial drugs or influence blood test results.

Trials commonly require screening blood tests, urine tests, observations such as blood pressure, an ECG, scans or questionnaires. There may also be practical criteria: ability to attend a particular hospital, consent to follow-up, use contraception where required, or keep a symptom diary. These are not minor details. If regular appointments are unrealistic because of work, caring commitments or travel, discuss this early.

How screening works in practice

Being referred to, or expressing interest in, a trial is not the same as being enrolled. The first contact may involve a short pre-screening discussion to establish whether the broad criteria appear suitable. The research team may then request permission to review medical records or seek information from your GP, consultant or hospital team.

If the study remains appropriate, you may be invited to a screening visit. This is a formal assessment against the protocol. The team will explain the study, discuss possible benefits and risks, and give you the participant information sheet. You should have time to read it, ask questions and decide whether you want to proceed.

Consent comes before research procedures that are not part of normal care, but consent does not guarantee enrolment. Screening can identify an issue that was not apparent from the initial information. Equally, criteria can change if a study closes recruitment, fills a particular participant group or is amended.

A practical guide to clinical trial eligibility checks

Preparation can make discussions more efficient and reduce avoidable delays. Keep a current record of your diagnosis, treatment history and medication. If you have hospital letters, clinic summaries, discharge documents, test results or imaging reports, have them available. The research team will decide what they need, but clear information helps them assess relevance quickly.

It is useful to note the dates of key events: when symptoms began, when your diagnosis was confirmed, treatments started and stopped, significant side effects and any recent admissions. If a trial involves a specific genetic or biomarker result, ask whether you have already had the relevant test and where the result can be obtained.

Be candid about your wider health, medicines and circumstances. Trying to minimise a condition or omit a supplement can place you at risk and may lead to withdrawal later. The safest route is a full clinical picture from the outset.

Before agreeing to screening, ask what the trial is trying to find out, whether there is a comparison treatment or placebo, how often visits are required, which costs may be reimbursed and what happens when the study ends. You may also want to ask whether taking part could affect access to other treatments or future studies. The answer depends on the individual trial and your clinical circumstances.

When you are not eligible

Ineligibility is common and should not be seen as a dead end. The reason may be temporary, such as a recent treatment, an abnormal result that needs follow-up, or a study that has already completed recruitment. Another trial may have different criteria, a different location or a more suitable recruitment window.

Ask the research team whether they can explain the reason in plain language and whether it may change over time. They cannot always recommend another study directly, but understanding the barrier can make a future search more focused. Your GP or specialist can also advise on established treatment options and whether a referral to the relevant hospital team is appropriate.

A clinical trial should complement, not replace, ordinary medical care. Continue to seek urgent help through appropriate NHS services for emergencies or rapidly worsening symptoms. Trials are carefully governed, but they are not a guaranteed route to a better outcome, and the potential benefits must be weighed against the demands and uncertainties of participation.

For people who want help making sense of trial criteria and preparing for a discussion with a research team, Clarity Medicine can provide practical, doctor-led clinical trial search and navigation support. A clear record of your health history and realistic expectations will put you in the strongest position to explore the options that may be available.